About SKAN Group AG 
SKAN Group AG
Pharmaceuticals & Biotechnology
BV Holding AG is a Switzerland-based holding company of an equity investment group, engaged in the participation in enterprises in Switzerland and bordering countries. It concentrates on companies from the industry, micro and medical technology, processing and material technology, information technology and related services. Target enterprises are those being in special situations, such as management buy-out and buy-in, changes in shareholders’ structure, succession financing, as well as coming through growth or expansion phase. The Company acts as an entrepreneurial partner in the long term. Operational activities are delegated to the independent advisor BV Partners AG. BV Holding AG and BV Partners AG form the BVgroup. As of December 31, 2011, its investment portfolio included nine companies: Covalys BioSciences AG, E2E Technologies Ltd., Lonstroff Holding AG, Piexon AG, POLYDATA AG, SKAN Holding AG, Sphinx Werkzeuge AG, Ypsomed Holding AG and Ziemer Group AG.
Company Coordinates 
Company Details
Hofgut, Vordere Dorfgasse 12 , GUEMLIGEN None : 3073
Registrar Details
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Management
Designation
Mr. Ernst Balmer
Chairman of the Board of Directors
Dr. Willy Michel
Vice Chairman of the Board of Directors
Dr. Rubino Mordasini
Member of the Board of Directors
Mr. Thomas Plattner
Member of the Board of Directors
Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
Pharmaceuticals & Biotechnology
CHF 1,088 Million ()
39.00
NA
38.49%
-1.53
17.36%
6.14






